Alnylam Pharmaceuticals, Inc. - Common Stock financial statements
Annual and standalone quarterly facts filed by the company with the SEC. Monetary values are shown in USD millions; per-share values use USD.
Filed statements
| USD; millions except EPS | Jun 2026Filed 30/07/2026 | Mar 2026Filed 30/07/2026 | Sep 2025Filed 30/10/2025 | Jun 2025Filed 30/07/2026 | Mar 2025Filed 30/07/2026 | Sep 2024Filed 30/10/2025 | Jun 2024Filed 30/10/2025 | Mar 2024Filed 30/10/2025 |
|---|---|---|---|---|---|---|---|---|
| $1,291 | — | $1,249 | $774 | $594 | $501 | $660 | $494 | |
| $164 | $206 | $251 | −$72 | −$18 | −$112 | −$17 | −$66 | |
| $1.21 | — | $1.84 | −$0.55 | −$0.14 | −$0.87 | −$0.13 | −$0.52 | |
| 138 | — | 137 | 131 | 130 | 129 | 127 | 126 |
Trend